CASSI SMITHEM: Open Payments
NPI 1730810961 · NEWBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 26 payments from 9 companies in 2025. Trend: 2023 $771 · 2024 $2,190 · 2025 $559
Food & beverage: $550Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $180 |
| Regeneron Healthcare Solutions, Inc. | 4 | $114 |
| UCB, Inc. | 2 | $70 |
| Incyte Corporation | 2 | $52 |
| Lilly USA, LLC | 2 | $49 |
| Arcutis Biotherapeutics, Inc. | 2 | $36 |
| LEO Pharma Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Organon LLC | 1 | $16 |
Products named: SKYRIZI, DUPIXENT, Bimzelx, OPZELURA, TALTZ, RINVOQ, Zoryve, ADBRY.
Industry payments across NY — which companies pay providers there.
